Efficacy of beta-blockers on blood pressure control and morbidity and mortality endpoints in hypertensives of African ancestry: an individual patient data meta-analysis
IntroductionCompared with first-line antihypertensives, beta-blockers (BB) have been reported to lower the central aortic blood pressure suboptimally and are associated with increased stroke risk. This observation has not been investigated in hypertensives of African ancestry. We hypothesised that a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-01-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1280953/full |
| _version_ | 1797348549712674816 |
|---|---|
| author | Nqoba Tsabedze R. Darshni Naicker Sanaa Mrabeti |
| author_facet | Nqoba Tsabedze R. Darshni Naicker Sanaa Mrabeti |
| author_sort | Nqoba Tsabedze |
| collection | DOAJ |
| description | IntroductionCompared with first-line antihypertensives, beta-blockers (BB) have been reported to lower the central aortic blood pressure suboptimally and are associated with increased stroke risk. This observation has not been investigated in hypertensives of African ancestry. We hypothesised that an individual patient data meta-analysis (IPD-MA) on the efficacy of second- or third-generation beta-blockers (STGBBs) in hypertensives of African descent may provide new insights.MethodsA single-stage IPD-MA analysed the efficacy of STGBB in lowering the mean arterial blood pressure and reducing the composite outcomes: cardiovascular death, stroke, and myocardial infarction.ResultsA total of 11,860 participants from four randomised control trials were included in the analysis. Second- or third-generation beta-blockers reduced the mean arterial pressure by 1.75 mmHg [95% confidence interval (CI):1.16–2.33; P < 0.001] in all participants included in the analysis, and by 1.93 mmHg (95% CI: 0.86–3.00; P < 0.001) in hypertensive Africans. In patients with established cardiovascular disease, where the benefits of BB therapy are well established, STGBBs were associated with an adjusted odds ratio of 1.33 (95% CI: 1.06–1.65; P = 0.015) of the composite outcome, most likely due to confounding. Similarly, the risk of total myocardial infarction was 1.76 times higher (95% CI: 1.15–2.68; P = 0.008) in hypertensives of African ancestry on STGBBs.ConclusionThe STGBBs reduced the mean arterial pressure comparably to other antihypertensives, and they were not associated with an increased risk of stroke. |
| first_indexed | 2024-03-08T12:07:36Z |
| format | Article |
| id | doaj.art-4a53285cb00e4d10af972943800af7df |
| institution | Directory Open Access Journal |
| issn | 2297-055X |
| language | English |
| last_indexed | 2024-03-08T12:07:36Z |
| publishDate | 2024-01-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj.art-4a53285cb00e4d10af972943800af7df2024-01-23T04:35:47ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2024-01-011010.3389/fcvm.2023.12809531280953Efficacy of beta-blockers on blood pressure control and morbidity and mortality endpoints in hypertensives of African ancestry: an individual patient data meta-analysisNqoba Tsabedze0R. Darshni Naicker1Sanaa Mrabeti2Division of Cardiology, Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South AfricaMedical Department, Healthcare Division, Merck Pty Ltd, Modderfontein, South AfricaMedical Affairs EMEA, Merck Serono Middle East FZ-LLC, Dubai, United Arab EmiratesIntroductionCompared with first-line antihypertensives, beta-blockers (BB) have been reported to lower the central aortic blood pressure suboptimally and are associated with increased stroke risk. This observation has not been investigated in hypertensives of African ancestry. We hypothesised that an individual patient data meta-analysis (IPD-MA) on the efficacy of second- or third-generation beta-blockers (STGBBs) in hypertensives of African descent may provide new insights.MethodsA single-stage IPD-MA analysed the efficacy of STGBB in lowering the mean arterial blood pressure and reducing the composite outcomes: cardiovascular death, stroke, and myocardial infarction.ResultsA total of 11,860 participants from four randomised control trials were included in the analysis. Second- or third-generation beta-blockers reduced the mean arterial pressure by 1.75 mmHg [95% confidence interval (CI):1.16–2.33; P < 0.001] in all participants included in the analysis, and by 1.93 mmHg (95% CI: 0.86–3.00; P < 0.001) in hypertensive Africans. In patients with established cardiovascular disease, where the benefits of BB therapy are well established, STGBBs were associated with an adjusted odds ratio of 1.33 (95% CI: 1.06–1.65; P = 0.015) of the composite outcome, most likely due to confounding. Similarly, the risk of total myocardial infarction was 1.76 times higher (95% CI: 1.15–2.68; P = 0.008) in hypertensives of African ancestry on STGBBs.ConclusionThe STGBBs reduced the mean arterial pressure comparably to other antihypertensives, and they were not associated with an increased risk of stroke.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1280953/fullhypertensionbeta-blockerantihypertensiveindividual patient data meta-analysiscardiovascular outcomesAfrica |
| spellingShingle | Nqoba Tsabedze R. Darshni Naicker Sanaa Mrabeti Efficacy of beta-blockers on blood pressure control and morbidity and mortality endpoints in hypertensives of African ancestry: an individual patient data meta-analysis Frontiers in Cardiovascular Medicine hypertension beta-blocker antihypertensive individual patient data meta-analysis cardiovascular outcomes Africa |
| title | Efficacy of beta-blockers on blood pressure control and morbidity and mortality endpoints in hypertensives of African ancestry: an individual patient data meta-analysis |
| title_full | Efficacy of beta-blockers on blood pressure control and morbidity and mortality endpoints in hypertensives of African ancestry: an individual patient data meta-analysis |
| title_fullStr | Efficacy of beta-blockers on blood pressure control and morbidity and mortality endpoints in hypertensives of African ancestry: an individual patient data meta-analysis |
| title_full_unstemmed | Efficacy of beta-blockers on blood pressure control and morbidity and mortality endpoints in hypertensives of African ancestry: an individual patient data meta-analysis |
| title_short | Efficacy of beta-blockers on blood pressure control and morbidity and mortality endpoints in hypertensives of African ancestry: an individual patient data meta-analysis |
| title_sort | efficacy of beta blockers on blood pressure control and morbidity and mortality endpoints in hypertensives of african ancestry an individual patient data meta analysis |
| topic | hypertension beta-blocker antihypertensive individual patient data meta-analysis cardiovascular outcomes Africa |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1280953/full |
| work_keys_str_mv | AT nqobatsabedze efficacyofbetablockersonbloodpressurecontrolandmorbidityandmortalityendpointsinhypertensivesofafricanancestryanindividualpatientdatametaanalysis AT rdarshninaicker efficacyofbetablockersonbloodpressurecontrolandmorbidityandmortalityendpointsinhypertensivesofafricanancestryanindividualpatientdatametaanalysis AT sanaamrabeti efficacyofbetablockersonbloodpressurecontrolandmorbidityandmortalityendpointsinhypertensivesofafricanancestryanindividualpatientdatametaanalysis |